SNMMI Podcast Series

Join moderator Lance Burrell and guests Mike Pintek, President, Nuclear & Precision Health Solutions (NPHS) and Dr. Ramji Rajendran, Radiation Oncologist, UroPartners, LLC, Medical Director of Theranostics and Radiation Oncologist with The Specialty Alliance as they speak about Alpha Therapy. This podcast is sponsored by Cardinal Health, a Value Initiative member. Disclaimer: The clinical views and opinions expressed in this presentation are those of the speakers and are based on their personal clinical experience. It should not be considered medical guidance. Any mention of a specific product is for illustration purposes.Any verbal evaluations and opinions expressed by clinicians are independent and not approved by Cardinal Health.This discussion addresses early-stage research, isotope supply, and operational considerations. Actinium-225-related applications discussed here are investigational unless and until specifically approved in product labeling. No statement should be interpreted as a recommendation regarding safety, effectiveness, patient selection, or standard-of-care use.Health care providers are responsible for all medical decisions regarding the use of any drug products with their patients.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Join United Imaging, an SNMMI Value Initiative member, for an insightful discussion with moderator Lance Burrell and speakers Jennifer Robinson, Amanda Dieselkamp, and Will Cofer on the evolving role of mobile PET CT in expanding access to advanced molecular imaging. This podcast is brought to you by United Imaging, an SNMMI Value Initiative member. Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Was medical physicist an option at your school's career day? If so, lucky you! But if not, you're not alone. It's a pretty niche field, but it has a significant impact on the future of personalized medicine and treating diseases. If you're thinking that this sounds like an intriguing career path, we're joined by physicists working in several different areas of nuclear medicine: quality control, equipment calibration, and research. Ben Auer, PhD, hosts this episode as we learn more about how our guests discovered their career in medical physics, the qualifications needed, and the various opportunities that come with this highly rewarding field. Tune in now!This episode of the Podcast is sponsored by GE HealthCare.Vizamyl Important Safety InformationPRODUCT INDICATIONS AND USEVIZAMYL™(flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:Evaluation of Alzheimer's disease(AD) and other causes of cognitive declineSelection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing(2%), increased blood pressure(2%), headache nausea and dizziness(1%).Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

This year, 125.6 million people tuned in to watch the Seahawks face the Patriots in the Super Bowl. While the game was the main draw, it's perhaps the one time of year that commercials generate equal excitement. 2026 was no exception, but before the first quarter ended, it was clear which industry dominated the 2026 ad buys: artificial intelligence. AI has become ubiquitous in daily life, and there's almost no industry that hasn't been impacted by its adoption, including nuclear medicine. While some of its applications are clear, questions remain about how AI will be used in clinical settings, patient interactions, image interpretation, and more. On this episode of the SNMMI Podcast, Lance Burrell moderates a discussion with Dmitry Beyer, MPA, CNMT, and Samantha Heasty on AI and its capabilities, potential, and shortcomings. Tune in now!This episode of the SNMMI Podcast is sponsored by GE Healthcare.Important Safety Information – VIZAMYLPRODUCT INDICATIONS AND USEVIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:· Evaluation of Alzheimer’s disease (AD) and other causes of cognitive decline· Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-piWant more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

So much of what we know about heart health is based on male models. Classic heart attack symptoms describe the experiences of men, drugs were developed largely by men for men—even in research, mouse models were male. But in recent years, our understanding of women's cardiac health has expanded, and critically, we have learned that we cannot simply apply male models to female patients. As one of our guests says, "women are not small men." For American Heart Month, join us for a heart-to-heart with members of the SNMMI Cardiovascular Council as they discuss how nuclear cardiology is providing new insight into women's heart health. Listen here or wherever you stream your podcasts. This episode of the SNMMI Podcast is sponsored by GE Healthcare.Important Safety Information – VIZAMYLPRODUCT INDICATIONS AND USEVIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:· Evaluation of Alzheimer’s disease (AD) and other causes of cognitive decline· Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-piWant more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Join Phillip Kuo, MD, PhD, and Jacob Dubroff, MD, PhD as they delve into discussions about the latest tracers, brain imaging techniques, and advances in patient care. To learn more about advancements in neurology in nuclear medicine, register for the upcoming SNMMI Mid-Winter Meeting with a dedicated neurology track. Register Here: https://snmmi.org/MWM/MWM/Attend/Register.aspx Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Join Lance Burrell for a continued conversation on nuclear medicine physicians of the future with Munir Ghesani, MD and Jean-Luc Urbain, MD, PhD. Together, they cover the medical student curriculum, current programs available, and the future of nuclear medicine.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Join Lance Burrell for an insightful conversation with Dr. Gary Ulaner, as they discuss the role of nuclear medicine in breast cancer treatment and lesser-known breast cancer types.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Join Dr. Faraz Farhadi and Dr. Navid Hasani as they discuss solutions to recruiting nuclear medicine physicians and expanding the pipeline of trainees.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

This podcast is brought to you by Lilly, member of the SNMMI Value Initiative Industry Alliance. Hosts Anupa Arora, MD and Anthony “Nino” Sireci, MD discuss a New Era in Alzheimer Diagnostics. This episode takes a focused look at high-impact topics shaping the future of Nuclear Medicine and Molecular Imaging, designed specifically for professionals driving value in the field. Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

June is Alzheimer's and Brain Awareness month, join Phillip Kuo, MD, PhD as he delves into the history of neurodegenerative disorders and the progress nuclear medicine has made to help diagnose and treat diseases like dementia and Alzheimer’s. Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Join Bonnie Clarke, Senior Director of Research and Development at SNMMI, and Richard Wahl, MD, Mallinckrodt Institute of Radiology Professor, past president of SNMMI, and founder of the Mars Shot, as they talk about the Radiopharmaceutical Therapy Centers of Excellence (RPTCOE) program and see how nuclear medicine plays a key role in patient care. Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

In this special American Heart Month episode, Lance Burrell—nuclear medicine technologist and SNMMI Research and Discovery imaging specialist—sits down with Dr. Richard Weinberg, MD, PhD, the Medical Director of Nuclear Cardiology at Northwestern’s Bluhm Cardiovascular Institute and President of the SNMMI Cardiovascular Council. Dr. Weinberg shares expert insights on the critical role of nuclear medicine in heart health, the latest advancements in nuclear cardiology, and the power of prevention in cardiovascular care.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

This podcast is brought to you by GE HealthCare, an SNMMI Value Initiative member. This podcast asks about AI's promise in nuclear medicine in image acquisition, image reconstruction, post processing, computer diagnosis has been promising, but clinical adoption will require AI to provide a higher value compared to the standard of care. This podcast will ask question such as how can AI provide this improved bio nuclear medicine? What are some of the strategies that can help us with AI demonstrating clinical value? What are some of the initiatives that we can take as a society and as a community to strengthen this value, and how can we rally the community to take steps towards strengthening this value? Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

This podcast is brought to you by GE HealthCare, an SNMMI Value Initiative member.  Hosts Zhiyong Lu, PhD and Jong Chul Ye, PhD speak about emerging territories in the broadening domain of Artificial Intelligence and learning about generative AI. Dr. Lu will speak the work he has done in AI in the context national language processing. Dr. Ye will speak on generative AI in imaging. Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

This podcast is brought to you by United Imaging, co-chair of the SNMMI Value Initiative Industry Alliance. Hosts Munir Ghesani, MD, former President of SNMMI, co-chair of the Mars Shot Research Fund, and Stephen Lokitz, MD, a Nuclear Medicine physicist and Executive Director and Director of Imaging Sciences at the Center for Molecular Imaging and Therapy, or CMIT, discuss nuclear medicine procedures performed and their plans for the future.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

This episode is a recorded presentation delivered by Robert Gatenby, MD from the Moffitt Cancer Center during the opening plenary at the SNMMI 2024 Artificial Intelligence Summit, "AI In Action" held Feb 29 - March 1, 2024.  Dr. Gatenby has used evolutionary dynamics models to develop an adaptive therapy approach for the treatment of cancer which he describes during his talk.  Join this podcast and discover an innovative and effective approach to treating cancer – the use of evolutionary biology, mathematical oncology and radiopharmaceutical therapy.  Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Drs. Jon McConathy, David A. Wolk, and Illya M. Nasrallah provide an update and information about neuro imaging related to Alzheimer's disease, particularly amyloid and tau imaging.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Dr. Tina Buehner, Dr. Remo George, Jose “Freddy” Gonzalez, and Erika Padilla-Morales discuss the importance of research in advancing nuclear medicine and the impact of research on patient care and the future of molecular imaging.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Dr. Stephen A. Graves and Dr. Andrei Iagaru discuss the opportunities, threats, challenges, trends, and lessons learned regarding radiopharmaceutical therapy with moderator Dr. Phillip J. Koo.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Dr. Jean-Mathieu Beauregard and Dr. Carlos Uribe discuss the present, future, and implications of dosimetry with moderator Dr. John Sunderland.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

In part 2 of a conversation with Dr. Stephen Graves and Dr. Benjamin Auer, our two experts continue their discussion on quantitative SPECT, its place in regards to PET, requirement, and current status.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

In part 1 of a conversation with Dr. Stephen Graves and Dr. Benjamin Auer, our two experts discuss quantitative SPECT, its place in regards to PET, requirement, and current status.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Umar Mahmood, MD, PhD, and Andrei Iagaru, MD—the inaugural recipient of the Sam Gambhir Trailblazer Award—discuss Dr. Gambhir's life and legacy, including personal and professional recollections. Dr. Iagaru also shares his thoughts on the future of nuclear medicine therapies, what keeps him motivated, and more.This new SNMMI award was created in memory of Sanjiv 'Sam' Gambhir, MD, PhD, who passed away in July 2020. He was Professor and Chair of Radiology at the Stanford School of Medicine and an internationally recognized pioneer in molecular imaging. The Sam Gambhir Trailblazer Award honors outstanding achievement in excellence in transformative research (either basic science, translational science or clinical science) and exceptional mentorship for mid-career professionals.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

This episode features Simon Cherry, PhD, discussing his recent 2022 Annual Meeting Cassen Award Lecture and more in a wide-ranging conversation with SNMMI President, Munir Ghesani, MD.In his lecture—A Matter of Time—at the SNMMI 2022 Annual Meeting, Cassen Award Winner Simon Cherry, PhD , explored time, and its role in nuclear medicine, from historical developments occurring over decades, to technologies that can detect photons with a precision of tens of picoseconds. Inspired by the groundbreaking ideas of Benedict Cassen and others, Dr. Cherry charted the journey from the past and into the future to create the ultimate imaging devices for studying the body and its many interacting systemsThe Benedict Cassen Prize is awarded by the Education and Research Foundation (ERF) for Nuclear Medicine and Molecular Imaging in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science.Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Heather Jacene, MD, SNMMI Scientific Program Chair, sits for a conversation with E.G. Elisabeth de Vries, MD, PhD—the SNMMI 2022 Annual Meeting Henry N. Wagner, Jr., MD, Lectureship Speaker—for a preview of her lecture: Seeing the Light with Molecular Imaging for Systemic Cancer Treatment Decisions. Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X